- Pediatric Practice and Research
- Volume:7 Issue:Ek - IRUPEC 2019 Kongresi Tam Metin Bildirileri
- Clinical and Immunological Findings of a Child with Cell Division Cycle 42 mutation
Clinical and Immunological Findings of a Child with Cell Division Cycle 42 mutation
Authors : Ekrem ÜNAL, Türkan PATİROĞLU
Pages : 71-71
View : 25 | Download : 9
Publication Date : 2019-12-10
Article Type : Conference Paper
Abstract :A male patient who is on 4,5 year of age, was admitted the neonatal intensive care unit because of anemia, thrombocytopenia, neutropenia and high acute phase reactans insert ignore into journalissuearticles values(APR); at the 20 day of age. Patient was diagnosed septicemia. At the 40 day of age, persistant fever, rash and hepatosplenomegaly developed. Patient was diagnosed Hemophagocytic lymphohistiocytosis, and treated intravenous immunoglobulin insert ignore into journalissuearticles values(IVIG); and steroid. An anemia, thrombocytopenia, neutropenia and high APR repeated at sixth month of age. Patient suffered from mucosal and intracranial bleading. Anemia and thrombocytopenia regressed, but neutropenia persisted in the following months. Pamidronate treatment was started for diagnosis of osteoporosis at the 21 month of age. Patient had hypotonia and mental, motor retardation. Fever with rash attacs started at 2 year of age, patient treated with anakinra for diagnosis of CAPS . There is no detected a mutation NLRP3 gene. An anemia without requirement of transfusion and neutropenia persisted on the following time. By the Whole exon sequensing, heterozygous missense variation CDC42insert ignore into journalissuearticles values(LRG_1326t1:c556C>T;pArg186Cys); was detected. CDC42 is a member of the Rashomolog insert ignore into journalissuearticles values(Rho); GTPase family, which controls a range of cellular processes including adhesion, migration, polarity, cell cycle and proliferation. It acts as a key to control GTP and GDP conversionsinsert ignore into journalissuearticles values(1);. NOARCH syndrome was newly described at 4 patients as neonatal onset pancytopenia, autoinflammation, rash and episodic HLH on 2019 insert ignore into journalissuearticles values(2);.Keywords : We would like to thank Prof Dr Christoph KLEIN